⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

December 1, 1989Archives of Neurology

Selegiline as an Adjunct to Conventional Levodopa Therapy in Parkinson's Disease

View Full Paper

Ask AI

Bookmark

Share

Authors

TETeresita S. ElizanIcahn School of Medicine at Mount Sinai

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Teresita S. Elizan (1989) studied this question.

synapsesocial.com/papers/6a83f8db2ccfc61f58b06f86 https://doi.org/10.1001/archneur.1989.00520480022013

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

1Deprenyl in Parkinson disease1981 · 88 citations
2Monoamine Oxidase Activity and Monoamine Metabolism in Brains of Parkinsonian Patients Treated with <i>l</i>‐Deprenyl1986 · 243 citations
3Inhibition of Biogenic Amine Uptake by Hydrogen Peroxide: A Mechanism for Toxic Effects of 6-Hydroxydopamine1971 · 204 citations